Net Loss Per Share Attributable to Common Stockholders (Tables)

12 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Computation Of Basic And Diluted Net Loss Per Share Attributable To Common Stockholders

Basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2025 and 2024 was calculated as follows (in thousands, except share and per share data):

	Year Ended December 31,
	2025			2024
Numerator:
Net loss attributable to common stockholders, basic and diluted	$	(43,438	)	$	(69,167	)
Denominator:
Weighted average common shares outstanding		15,268,733			1,358,586
Less: Weighted-average common shares subject to repurchase		(916	)		(22,661	)
Weighted-average shares outstanding, basic and diluted		15,267,817			1,335,925
Net loss per share attributable to common stockholders, basic and diluted	$	(2.85	)	$	(51.77	)

As described in Note 12, the Pre-Funded Warrants to purchase up to an aggregate of 800,000 shares of the Company’s common stock at a purchase price of $9.9999 per Pre-Funded Warrant were classified as a component of equity in the Company's consolidated balance sheet as they are freestanding financial instruments that are immediately exercisable, do not embody an obligation for the Company to repurchase its own shares and permit the holders to receive a fixed number of shares of common stock upon exercise. All of the shares underlying the Pre-Funded Warrants have been included in the weighted-average number of shares of common stock used to calculate basic and diluted net loss per common share for the year ended December 31, 2025, because the shares may be issued for little or no consideration, are fully vested, and are exercisable after the original issuance date of the Pre-Funded Warrants.

Potential Dilutive Securities Excluded From Computation Of Diluted Net Loss Per Share Attributable To Common Stockholders

The potential shares of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders as of December 31, 2025 and 2024 because including them would have had an anti-dilutive effect. The excluded shares were as follows:

	December 31,
	2025		2024
Redeemable convertible preferred stock, as converted		—		8,699,309
Outstanding options to purchase common stock		2,142,278		1,144,690
Unvested restricted stock awards		141		1,839
2024 Note1		—		3,360,787
Total		2,142,419		13,206,625

1 As of December 31, 2024, the conversion of the 2024 Note into common stock or redeemable convertible preferred stock was dependent on the price of shares that may be issued in connection with the 2024 Note Qualified Financing. The number of shares herein is calculated based on the conversion of the 2024 Note’s outstanding principal and accrued and unpaid interest as of December 31, 2024 into the Company’s preferred stock at the price of $6.20 per share.